Small-cell melanoma

From WikiMD's WELLNESSPEDIA


File:Skin Tumors-P6251259.jpg
Small-cell melanoma on the skin

Small-cell melanoma is a rare and aggressive form of melanoma, a type of skin cancer that originates in the melanocytes, the cells responsible for producing melanin, the pigment that gives skin its color. This variant of melanoma is characterized by the presence of small, round, and densely packed tumor cells.

Pathophysiology[edit]

Small-cell melanoma is distinguished by its unique histological appearance. The tumor cells are small, with scant cytoplasm and hyperchromatic nuclei. This form of melanoma can be challenging to diagnose due to its resemblance to other small-cell neoplasms, such as small-cell lung cancer. Immunohistochemical staining is often required to confirm the diagnosis, with markers such as S-100 protein, HMB-45, and Melan-A being positive in melanoma cells.

Clinical Presentation[edit]

Patients with small-cell melanoma may present with a variety of symptoms depending on the location and stage of the tumor. Commonly, it appears as a new or changing pigmented lesion on the skin. Due to its aggressive nature, small-cell melanoma can metastasize rapidly to other parts of the body, including the lymph nodes, lungs, liver, and brain.

Diagnosis[edit]

The diagnosis of small-cell melanoma involves a combination of clinical examination, dermoscopy, and histopathological analysis. A biopsy of the suspicious lesion is essential for definitive diagnosis. Pathologists look for the characteristic small-cell morphology and use immunohistochemical stains to differentiate it from other small-cell malignancies.

Treatment[edit]

Treatment options for small-cell melanoma are similar to those for other types of melanoma and may include surgical excision, immunotherapy, targeted therapy, and chemotherapy. The choice of treatment depends on the stage of the disease and the overall health of the patient. Early detection and treatment are crucial for improving the prognosis.

Prognosis[edit]

The prognosis for small-cell melanoma is generally poor due to its aggressive nature and tendency to metastasize early. The survival rate is lower compared to other forms of melanoma, emphasizing the importance of early detection and intervention.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.